These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21246774)

  • 21. Studying genotype-phenotype relationships: cardiovascular disease as an example.
    Herrmann SM; Paul M
    J Mol Med (Berl); 2002 May; 80(5):282-9. PubMed ID: 12021840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic profiling of human cell lines used as in vitro model to study cardiovascular pathophysiology and pharmacotoxicology.
    Jeannesson E; Siest G; Zaiou M; Berrahmoune H; Masson C; Visvikis-Siest S
    Cell Biol Toxicol; 2009 Dec; 25(6):561-71. PubMed ID: 19067187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression.
    Keren A; Syrris P; McKenna WJ
    Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):158-68. PubMed ID: 18227814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Are genetic tests useful for cardiovascular prevention?].
    Bochud M; Fellmann F; Guessous I
    Rev Med Suisse; 2012 Mar; 8(331):519-20, 522-4. PubMed ID: 22471114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic testing for cardiovascular disease susceptibility: a useful clinical management tool or possible misinformation?
    Humphries SE; Ridker PM; Talmud PJ
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):628-36. PubMed ID: 14715642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular biology in the diagnosis of cardiovascular diseases].
    Berg K
    Tidsskr Nor Laegeforen; 1998 Jun; 118(15):2370-4. PubMed ID: 9691807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primordial prevention of cardiovascular disease through applied genetics.
    Williams RR; Hopkins PN; Stephenson S; Wu L; Hunt SC
    Prev Med; 1999 Dec; 29(6 Pt 2):S41-9. PubMed ID: 10641817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular and genetic approaches to the study of cardiovascular disease.
    Hallman DM; Ellsworth DL; Boerwinkle E
    J Cardiovasc Risk; 1997; 4(5-6):325-31. PubMed ID: 9865662
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiovascular disease in kidney transplant recipients: the prognostic value of inflammatory cytokine genotypes.
    La Manna G; Cappuccilli ML; Cianciolo G; Conte D; Comai G; Carretta E; Scolari MP; Stefoni S
    Transplantation; 2010 Apr; 89(8):1001-8. PubMed ID: 20061995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic influences on the arterial wall.
    Kingwell B; Boutouyrie P
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):652-7. PubMed ID: 17581225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease Study.
    Shah SH; Granger CB; Hauser ER; Kraus WE; Sun JL; Pieper K; Nelson CL; Delong ER; Califf RM; Newby LK;
    Am Heart J; 2010 Sep; 160(3):371-379.e2. PubMed ID: 20826242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Candidate gene polymorphism in cardiovascular disease: the BIP cohort.
    Leshinsky-Silver E; Cheng S; Grow MA; Shoshana S; Scharf L; Lev D; Boaz M; Brunner D; Zimlichman R
    Isr Med Assoc J; 2006 Feb; 8(2):103-5. PubMed ID: 16544732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical validation of genetic markers for improved risk estimation.
    Kessler T; Schunkert H
    Eur J Prev Cardiol; 2012 Aug; 19(2 Suppl):25-32. PubMed ID: 22801067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic testing in cardiovascular disease.
    Robin NH; Tabereaux PB; Benza R; Korf BR
    J Am Coll Cardiol; 2007 Aug; 50(8):727-37. PubMed ID: 17707176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics 101 for cardiologists: rare genetic variants and monogenic cardiovascular disease.
    Farhan SM; Hegele RA
    Can J Cardiol; 2013 Jan; 29(1):18-22. PubMed ID: 23200093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular disease in type 2 diabetics: epidemiology, risk factors and therapeutic modalities.
    Khamaisi M; Wexler ID; Skrha J; Strojek K; Raz I; Milicevic Z
    Isr Med Assoc J; 2003 Nov; 5(11):801-6. PubMed ID: 14650106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype.
    Singhal S; Bevan S; Barrick T; Rich P; Markus HS
    Brain; 2004 Sep; 127(Pt 9):2031-8. PubMed ID: 15229130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additive effects of the chemokine receptor 2, vitamin D receptor, interleukin-6 polymorphisms and cardiovascular risk factors on the prevalence of myocardial infarction in patients below 65 years.
    Ortlepp JR; Krantz C; Kimmel M; von Korff A; Vesper K; Schmitz F; Mevissen V; Janssens U; Franke A; Hanrath P; Zerres K; Hoffmann R
    Int J Cardiol; 2005 Oct; 105(1):90-5. PubMed ID: 16207551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Personalized prognosis and diagnosis of type 2 diabetes--vision or fiction?
    Müller G
    Pharmacology; 2010; 85(3):168-87. PubMed ID: 20173359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.